BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22404438)

  • 41. Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up.
    Vannella L; Lahner E; Bordi C; Pilozzi E; Di Giulio E; Corleto VD; Osborn J; Delle Fave G; Annibale B
    Dig Liver Dis; 2011 Apr; 43(4):295-9. PubMed ID: 21112822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
    Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
    Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type III intestinal metaplasia, Helicobacter pylori infection and gastric carcinoma risk index in an Italian series of 1750 patients.
    Suriani R; Venturini I; Taraglio S; Mazzucco D; Grosso S; Predebon S; Mamo C; Tremosini S; Ballesini P; Borghi A; Zeneroli ML
    Hepatogastroenterology; 2005; 52(61):285-8. PubMed ID: 15783051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication.
    Kodama M; Murakami K; Okimoto T; Sato R; Uchida M; Abe T; Shiota S; Nakagawa Y; Mizukami K; Fujioka T
    J Gastroenterol; 2012 Apr; 47(4):394-403. PubMed ID: 22138891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
    Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
    Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease.
    Kim N; Park YS; Cho SI; Lee HS; Choe G; Kim IW; Won YD; Park JH; Kim JS; Jung HC; Song IS
    Helicobacter; 2008 Aug; 13(4):245-55. PubMed ID: 18665932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.
    Ciok J; Dzieniszewski J; Lucer C
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():115-22. PubMed ID: 9440062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea.
    Lee JH; Kim N; Chung JI; Kang KP; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Helicobacter; 2008 Aug; 13(4):288-94. PubMed ID: 18665939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
    Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.
    Matsuhisa T; Miki M; Yamada N; Sharma SK; Shrestha BM
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):295-301. PubMed ID: 18604043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
    Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
    Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
    Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.
    van der Hulst RW; van der Ende A; Dekker FW; Ten Kate FJ; Weel JF; Keller JJ; Kruizinga SP; Dankert J; Tytgat GN
    Gastroenterology; 1997 Jul; 113(1):25-30. PubMed ID: 9207258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia.
    Sharma P; Topalovski M; Mayo MS; Sampliner RE; Weston AP
    Am J Gastroenterol; 2000 Nov; 95(11):3107-11. PubMed ID: 11095325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of
    Yoon K; Kim N
    Korean J Gastroenterol; 2018 Sep; 72(3):104-115. PubMed ID: 30270592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of Helicobacter pylori eradication on body mass index and dyspeptic symptoms.
    Suto H; Yamazaki Y; Yoshida I; Yamakawa A; Ohtani M; Ito Y; Kuriyama M; Kato T; Azuma T
    Digestion; 2009; 79(4):235-42. PubMed ID: 19401613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection.
    Lahner E; Bordi C; Cattaruzza MS; Iannoni C; Milione M; Delle Fave G; Annibale B
    Aliment Pharmacol Ther; 2005 Sep; 22(5):471-81. PubMed ID: 16128686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of Helicobacter pylori eradication on chronic gastritis].
    Kodama M; Murakami K; Okimoto T; Fujioka T
    Nihon Rinsho; 2013 Aug; 71(8):1442-8. PubMed ID: 23967677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.